Sponsor:
M.D. Anderson Cancer Center
Code:
NCT04982653
Conditions
Liver and Intrahepatic Bile Duct Neoplasm
Metastatic Malignant Neoplasm in the Liver
Primary Malignant Liver Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quality-of-Life Assessment
Surgical Procedure
Surgical Procedure
Brief summary:
Conditions
Liver and Intrahepatic Bile Duct Neoplasm
Metastatic Malignant Neoplasm in the Liver
Primary Malignant Liver Neoplasm
Study ID
NCT04982653
Start date
Jan 4, 2022
Status verified date
May, 2026
Completion date
Feb 2, 2027
Anticipated
Primary completion date
Feb 2, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
140 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
experimental: Arm I (hepatectomy using small bites fascial closure)
active comparator: Arm II (hepatectomy using conventional fascial method)
Interventions
Quality-of-Life Assessment
Surgical Procedure
Surgical Procedure
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Timothy E. Newhook
Sponsor
M.D. Anderson Cancer Center
Last update posted
May 26, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-05-26.